0001179110-21-008582.txt : 20210903
0001179110-21-008582.hdr.sgml : 20210903
20210903160251
ACCESSION NUMBER: 0001179110-21-008582
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210902
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Srega Juergen
CENTRAL INDEX KEY: 0001569832
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 211236445
MAIL ADDRESS:
STREET 1: BRUKER CORPORATION
STREET 2: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
4
1
edgar.xml
FORM 4 -
X0306
4
2021-09-02
0
0001109354
BRUKER CORP
BRKR
0001569832
Srega Juergen
BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
0
1
0
0
Group President Bruker CALID
Common Stock
2021-09-02
4
M
0
90000
18.57
A
232877
D
Common Stock
2021-09-02
4
M
0
25369
20.68
A
258246
D
Common Stock
2021-09-02
4
M
0
35438
19.82
A
293684
D
Common Stock
2021-09-02
4
M
0
39468
22.19
A
333152
D
Common Stock
2021-09-02
4
S
0
202216
89.5397
D
130936
D
Stock Option (Right to Purchase)
18.57
2021-09-02
4
M
0
90000
0
D
2023-04-03
Common Stock
90000
0
D
Stock Option (Right to Purchase)
20.68
2021-09-02
4
M
0
25369
0
D
2024-08-08
Common Stock
25369
0
D
Stock Option (Right to Purchase)
19.82
2021-09-02
4
M
0
35438
0
D
2025-08-07
Common Stock
35438
0
D
Stock Option (Right to Purchase)
22.19
2021-09-02
4
M
0
39468
0
D
2026-10-04
Common Stock
39468
0
D
The stock option granted to the Reporting Person on April 3, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
The stock option granted to the Reporting Person on August 8, 2014 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.5014 to $90.15, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Sara Hussain, Attorney-in-Fact
2021-09-03
EX-24
2
ex24srega.txt
EXHIBIT 24
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints each of Sara Hussain, Michael Simone, and Michael Rich, signing singly,
as his/her true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as a director of Bruker Corporation (the "Company"), Forms
3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder and any other forms or
reports the undersigned may be required to file in connection with
the undersigned's ownership, acquisition, or disposition of
securities of the Company;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5, or other form or report, and timely file such form
or report with the U.S. Securities and Exchange Commission and any
stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned, pursuant to this
Power of Attorney, shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in his or
her discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform each and every act and thing whatsoever requisite,
necessary, and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or his or her
substitute or substitutes, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted. The undersigned
acknowledges that no such attorney-in-fact, in serving in such capacity at the
request of the undersigned, is hereby assuming any of the undersigned's
responsibilities to comply with Section 13 and Section 16 of the Securities
Exchange Act of 1934 and the rules thereunder, as amended.
This Power of Attorney shall remain in full force and effect until revoked
by the undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 6th day of August 2021.
/s/Juergen Srega
-----------------------------------------
August 6, 2021